Sports medicine physicians at Midwest Orthopaedics at Rush have recently partnered with the Instituto Brasil de Tecnologias da Saude (IBTS) and the Lemann Foundation on a new international fellowship program for Brazilian medical professionals in the early stages of their careers by creating collaborative educational and research opportunities with Midwest Orthopaedics at Rush physicians and researchers.
RUSH Partners With Instituto Brasil de Tecnologias da Saude
1 min read Premium comments
Secondary#midwestorthopaedicsatrush#institutobrasildetecnologiasdesaude
Areas of study will include biomechanics, 3D motion analysis, and others that aim to improve functional diagnosis, treatment decision making, optimized rehabilitation, and risks factor identification of orthopedic injuries.
“Education in the fields of sports medicine and arthroscopy has been a primary focus of ours over the last twenty years,” said Nikhil Verma, M.D., a sports medicine surgeon at Midwest Orthopaedics at Rush, and the director of the division of sports medicine at Rush University Medical Center.
“We have trained more than 100 domestic fellows and this new collaboration will allow us to expand our educational outreach in an international format.”
During the program, international fellows will be able to create networking bonds as well as have a strong mentorship experience.
“Combining our scientific efforts with IBTS will potentially impact millions of patients around the world,” said Brian Cole, M.D., sports medicine surgeon and managing partner at Midwest Orthopedics at Rush.
Leonardo Metsavaht, M.D., a sports medicine surgeon and one of the founders of IBTS, along with Drs. Verma and Cole have agreed to a five-year partnership during which two carefully selected Brazilian fellows will spend one year at Midwest Orthopaedics at Rush. The program will begin in August 2019.
Midwest Orthoapedics at Rush is located at Rush University Medical Center in Chicago, Illinois.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.